Hi all
pretty new to all this. I have pumped some into Deltex - looks like a strong product with good growth. Could be a steady gainer.
Does anyone else have this, and anyone have some research on it? Someone with more experience than me!
thanks in advance.
Grajul

And yet 2 sells of 1,000,000 plus come in just before close. Shows how punters are looking for any reason to sell on a decent uptick.
Deltex are the largest % of my portfolio, and whilst I am still very positive, especially since todays news, I feel I am in deep enough.

Sells of a million pounds? Surely you mean a million shares!!!

Anyway, I don't believe that they are sells, as the share price has gone UP substantially.

Weren't you guys saying this was a great buy at nearly double the current level ?

Morning Arf/Dil,

Arf, You are right of course, had a grey moment.

Dil, I for one wasn't. I had the sp at about right, due to the potential of the product balanced against the 'is this ever going to take off'.

I still think the sp is not worth double but with the current position, I feel it is just a tad undervalued.

To my mind there is hardly anything a great buy at double sp, unless of course you have insider knowledge.

If values are double, the market as a whole would be jumping in so quick that the sp would reach true value very quickly.

There are as ever exceptions.

Dil, I'm afraid your little grey cells must be fading, I have checked the period when DEMG were double the price and no one has mentioned buy, let alone great buy, the most bullish that I posted was post 440 ie 'Excellent sp performance over the last week or so, the message is getting through at last, 50%+ profit atm, but imo fwiw, we are only just scratching the surface and this could be an exciting and much more profitable ride.'
Same applies today really.
2517

Re post 681(The request by Hanover under Freedom of Information act).

On looking at the NHS Trust site they appear to have answered several requests placed in early October. As the Hanover/Deltex request was made late November, I would expect a reply or at least an update within the next 6 weeks.

I will keep everyone posted.

Note...No doubt as said the news released yesterday will push such Trusts to get moving (perhaps from being stationary to at least a slow crawl), or/and at least give Hanover a quicker response.

For info Norfolk and Norwich Hospital Trusts have on average about 12 such requests under the act per month.

Yet another study that proves the advantages of the CardioQ.
"It confirms the importance of CardioQ-ODM guided fluid management for patients undergoing moderate as well as major surgery."

I expect this to have very little effect on the SP, not because it is insignificant news by itself but because it is 'yet another' such report.

We know that there are now a multiple of these positive results (at the last count approaching 65). We also know how those that hold the purse strings can't see and decide on the obvious.

What points don't these muppets get, The CardioQ saves lives and money. What else is needed!

I am sure we are all frustrated by the continuing procrastination of the slow take up of the system. If I was connected with Deltex I would be looking for as many ways as possible of naming and shamming those who are dragging their feet.

The connection with Hanover must be given time to show results, but the time of treading softly softly has gone. The gloves must come off.

Holding up well in this market sell off, hope that's not put the kod on it.
2517

The Conservatives have announced that Hospitals will be fined if patients are sent home too early. This is due to around 500,000 patients being re-admitted to hospitals every year within 1 month of initial discharge.
Whilst I am sure we all appreciate that many patient will be re-admitted due to complications, mainly due to age related problems, I am sure we all also appreciate many patients are re-admitted because hospitals discharge then too quickly to save money/staff and to free beds. Often this is false economy as proven by the high cost of re-admittance.

So although fines in the end only hit the patents/taxpayers, and are in my opinion a bad idea and a waste of time, perhaps the threat of such fines might just make the hospital trust managers look at ways of reducing re-admission figures.

As we all know and are getting fed up saying it to anyone who will listen (which at the moment does not appears to include the cotton wool brained health trust decision makers) Deltex with their CardioQ can greatly assist in reducing re-admissions whilst also reducing initial treatment times.

How many more no brainer type of evidence do these job-worthies need.

Well worth a watch.

http://www.deltexmedical.com/latestnews.html

Excellent video, passing a message so irrefutable that makes you wonder what more is required for Hospital Trusts to take up the technology.
This should me rammed down the throats of the trust managers, (that's the message, not the video), although the video would at least force them to sit up and take notice.

Results.

Good but nothing to set the World on fire.

Investing in this share, is like pulling teeth.

Everything is up that should be, sales/margins.
Everything is down that should be, Operating loss/Cash consumed.
Several improvements in performance/take up of the CardioQ.

Things looking good for the next 12 months, problem being this has been the message for a couple of years now.

The management statement....'Deltex Medical is entering an exciting phase in its development. Robust clinical evidence, health economic benefit and convergence with key health policy objectives are becoming vitally important pre-requisites of success for developers of innovative medical technologies. Deltex Medical is well positioned to deliver sustainable increases in shareholder value through generating returns on the investments it has made to develop a compelling case in all these areas'.....is almost identical to last years and to some extent the year before.

I am not suggesting the above statement is 'hype' as they can only state what they feel is correct, but it must be so frustrating for the Deltex team as it is for their investors.

Not saying we won't get there but as already mentioned, cash is getting a bit tight and at the present pace it will run out in just over 12 months, but if all the positives carry on increasing pro- rata as they are, with losses reducing at the same degree, we can add another 6 months onto that.
So by my 'back of fag packet' calculations they have at most 18 months to break the back so to speak.

After that it will be another cash raising, with many PI's and probably several institutional backers thinking enough is enough.

Trying very hard to not let heart rule head as I have been with Deltex for many years, but it looks like they could join the many companies that have a fantastic product that fails to reach it's full potential.

Perhaps being a small fish in the big pond of medical devices (appreciate the CardioQ is out on it's own in technological terms) is not working. Would hate to see them taken out by a conglomerate, but it may come to that. When the 2008 results came out I said that they should either look for a partner (which I would prefer) or sell out to a company that has the required clout that they appear to lack.

How many of us feel that if Deltex was a USA equivalent they would be well in profit, up there with the big boys.

So still staying with it, but not expecting the sp to do much until /if they make that all important break out in sales.

My main worry is that investors start leaving in droves, as their patience wears even thiner than mine.

Extract from the interim results---------'The Company's key operational objective is to go into 2010 having passed the cash break-even point.' -----------Just not managed to achieve that, also concerned re NHS hospitals reigning back spending on monitors. Also let's not forget the placing for 2m only last October. All in all a bit disappointing imo.
2517

RNS,

Absolutely excellent read.
The reports compare all systems, mainly the PAC and Doppler with the Doppler coming out best.
The reports details are basically saying to the NHS trust Managers that, 'The Deltex CardioQ is a no brainer'. As there have been so many such positive reports 'WHAT PART OF THIS ARE THEY NOT GETTING'.
If this market review and buyers guide don't do the trick were the NHS is concerned then nothing will.

Down on the day.

Just shows how the market feels that the reports will have little effect at least in the short to medium term. I wonder how many copies are already sitting in waste paper bins, or languishing at the bottom of some job-worthies pending tray, whilst they read through the latest holiday brochure, car or fashion mag, or pondering how to spend some of the health budget on a new office suite.
Must get their priorities right.

Call me a miserable, moaning old git, who gets more cynical by the day.

OK not that old but the rest fits.

Todays RNS.

The Company also announces that it has today issued a total of 118,974 New Ordinary Shares to a certain adviser of the Company at a price of 13.00 pence per share.
Why can't we know who this adviser is, surely we as shareholders deserve to know. Whats the secret?

Peanut size bundles of shares bought today by 4 directors.
2517

Slow, drip, drip, drip of erosion.

After a three months high of 15.70 we are back at 11.75, where we were beginning of January, and the same as last May.
It appears the sp is being steadily eroded, often by amounts as small as .25p.
We need something, otherwise this will continue to trickle along a base of 11 to 12p.
As often said by myself and many others, the technology is excellent, but it needs to sell.
My faith is quickly eroding, which I admit just does not compute with the steady but slow increase in sales.
Perhaps it is the grey, depressing morning that is getting me down, but I would like to see a good profit on this share, whilst I'm still young enough to enjoy it.
It is very sole destroying, when you see a company struggling when they have a product that you believe in, but it appears that few others feel the same.

greekman, the market is littered with such companies ie TAN, the plastic bag co, Timestrip (tickers escape me for the last two) and others, some will come through and prosper, others just soak up and lose investors money. As far as DEMG I think it will be a winner, progress is slow, but it is progress. Hopefully more and more patients will be using the cardio Q etc, and our patience will be rewarded. The drawback is it's money tied up which could be used elsewhere.
2517

A 1,446,446 trade just gone through at mid price, and the sp never moved, even after the drop yesterday, coupled with what look like net sells over the last few weeks, so looks like a buy.

Deltex Medical Group plc has today been informed that, on 31 March 2010, Nigel J Keen, Chairman of Deltex Medical, transferred 1,446,446 ordinary shares of 2p each in the Company (the "Shares") at 11.625p each into the name of Nigel J Keen and Caroline J Keen, trustees of the Imperialise Pension Fund.

So it was a transfer, not a buy or a sell. So why did this trade go through as an ordinary market trade.

To say we are supposed to have more clarity in the markets, this was as clear as mud.